Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer

被引:0
|
作者
Kim, Heejung [1 ]
Shin, Eunbi [1 ]
Lee, JooHyun [1 ]
Yoo, Ran Ji [1 ]
Park, Jang Woo [1 ]
Chung, Hye Kyung [1 ]
Shim, Jae-Hoon [1 ]
机构
[1] Korea Inst Radiol & Med Sci KIRAMS, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
SP-124
引用
收藏
页码:S104 / S105
页数:2
相关论文
共 50 条
  • [31] Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers
    Min, Yijia
    Chen, Yu
    Wang, Lei
    Ke, Yong
    Rong, Fan
    He, Qunye
    Paerhati, Pameila
    Zong, Huifang
    Zhu, Jianwei
    Wang, Yin
    Zhang, Baohong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278
  • [32] 177Lu-Labeled and Trastuzumab-Conjugated Gold Nanoparticles Exhibit Multivalent Binding, High Uptake and Retention in HER2-Positive Breast Cancer Cells and Potent Cytotoxicity
    Cai, Z.
    Yook, S.
    Lu, Y.
    Winnik, M. A.
    Pignol, J.
    Reilly, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S530 - S530
  • [33] Antibody-drug conjugates are active in patients with HER2-positive breast cancer brain metastases: where do we go from here?
    Sammons, S.
    Lin, N. U.
    ESMO OPEN, 2024, 9 (05)
  • [34] Theranostic antibody-drug conjugates for potential dual application in targeted therapy and fluorescence imaging of colorectal cancer
    Ren, Siyuan
    Sun, Xiang
    Xu, Hua
    Trung Hai Nguyen
    Kang, Chi Soo
    Sadeghipour, Negar
    Xu, Xiaochun
    Wu, Ningjie
    Chen, Yu
    Tichauer, Kenneth
    Minh, David
    Hyun Chong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [35] Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directions
    Yu, Jiazheng
    Li, Mingyang
    Liu, Xiandong
    Wu, Siyu
    Li, Rong
    Jiang, Yuanhong
    Zheng, Jianyi
    Li, Zeyu
    Xin, Kerong
    Xu, Zhenqun
    Li, Shijie
    Chen, Xiaonan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [36] Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators
    D'Huyvetter, Matthias
    Aerts, An
    Xavier, Catarina
    Vaneycken, Ilse
    Devoogdt, Nick
    Gijs, Marlies
    Impens, Nathalie
    Baatout, Sarah
    Ponsard, Bernard
    Muyldermans, Serge
    Caveliers, Vicky
    Lahoutte, Tony
    CONTRAST MEDIA & MOLECULAR IMAGING, 2012, 7 (02) : 254 - 264
  • [37] Assessment of theranostic potential of Lu-177-trastuzumab in HER2 expressing breast cancer patients
    Shukla, J.
    Bhusari, P.
    Vatsa, R.
    Singh, G.
    Bal, A.
    Parmar, M.
    Dhawan, D. K.
    Mittal, B. R.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S28 - S28
  • [38] Preclinical evaluation of a promising novel, antibody-based 177Lu-labeled radiopharmaceutical for potential use in advanced thyroid cancer
    Mortensen, A.
    Berglund, H.
    Juhlin, C.
    Stenman, A.
    Jha, P.
    Frejd, F.
    Zedenius, J.
    Nestor, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S440 - S441
  • [39] Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models
    Li, Cuicui
    Liu, Jun
    Yang, Xu
    Yang, Qi
    Huang, Wenpeng
    Zhang, Mingyu
    Zhou, Dandan
    Wang, Rong
    Gong, Jianhua
    Miao, Qingfang
    Kang, Lei
    Yang, Jigang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 168 - 183
  • [40] Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer
    Duro-Sanchez, Santiago
    Nadal-Serrano, Mercedes
    Lalinde-Gutierrez, Marta
    Arenas, Enrique Javier
    Morales, Cristina Bernado
    Morancho, Beatriz
    Escorihuela, Marta
    Perez-Ramos, Sandra
    Escriva-de-Romani, Santiago
    Gandullo-Sanchez, Lucia
    Pandiella, Atanasio
    Esteve-Codina, Anna
    Rodilla, Veronica
    Dijcks, Fred A.
    Dokter, Wim H. A.
    Cortes, Javier
    Saura, Cristina
    Arribas, Joaquin
    CANCER RESEARCH, 2022, 82 (24) : 4670 - 4679